Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses

Nucleic Acids Research

Volumn 41, Issue 7, 2013, Pages 4036-4048

  Bolt, Michael J ^a   Stossi, Fabio ^a   Newberg, Justin Y ^a   Orjalo, Arturo ^b   Johansson, Hans E ^b   Mancini, Michael A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Biosearch Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR; MED14 PROTEIN; NUCLEAR RECEPTOR COACTIVATOR 2; REGULATOR PROTEIN; STEROID RECEPTOR COACTIVATOR 3; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CHROMATIN; CONTROLLED STUDY; DNA BINDING; GENE TARGETING; HORMONE ACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; VALIDATION PROCESS;

CELL LINE, TUMOR; CHROMATIN; ESTROGEN RECEPTOR ALPHA; GENES, REPORTER; HELA CELLS; HUMANS; MEDIATOR COMPLEX; NUCLEAR RECEPTOR COACTIVATOR 2; NUCLEAR RECEPTOR COACTIVATOR 3; NUCLEAR RECEPTOR COACTIVATORS; PROLACTIN; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION, GENETIC;

EID: 84876554683     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt100     Document Type: Article

References (50)

1. Horner-Glister, E., Maleki-Dizaji, M., Guerin, C.J., Johnson, S.M., Styles, J. and White, I.N. (2005) Influence of oestradiol and tamoxifen on oestrogen receptors-alpha and-beta protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells. J. Mol. Endocrinol., 35, 421-432. (Pubitemid 43025569)
2. Ogawa, S., Eng, V., Taylor, J., Lubahn, D.B., Korach, K.S. and Pfaff, D.W. (1998) Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. Endocrinology, 139, 5070-5081. (Pubitemid 28533455)
3. Rudnik, V., Sanyal, A., Syed, F.A., Monroe, D.G., Spelsberg, T.C., Oursler, M.J. and Khosla, S. (2008) Loss of ERE binding activity by estrogen receptor-alpha alters basal and estrogen-stimulated bone-related gene expression by osteoblastic cells. J. Cell. Biochem., 103, 896-907. (Pubitemid 351240625)
4. Tobias, J.H., Steer, C.D., Vilarino-Guell, C. and Brown, M.A. (2007) Estrogen receptor alpha regulates area-adjusted bone mineral content in late pubertal girls. J. Clin. Endocrinol. Metab., 92, 641-647.
5. Pike, A.C. (2006) Lessons learnt from structural studies of the oestrogen receptor. Best Pract. Res., 20, 1-14. (Pubitemid 43328570)
6. Spears, M. and Bartlett, J. (2009) The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer. Expert Opin. Ther. Targets, 13, 665-674.
7. Lee, J.E., Kim, K., Sacchettini, J.C., Smith, C.V. and Safe, S. (2005) DRIP150 coactivation of estrogen receptor alpha in ZR-75 breast cancer cells is independent of LXXLL motifs. J. Biol. Chem., 280, 8819-8830. (Pubitemid 40409571)
8. Bernardo, G.M., Lozada, K.L., Miedler, J.D., Harburg, G., Hewitt, S.C., Mosley, J.D., Godwin, A.K., Korach, K.S., Visvader, J.E., Kaestner, K.H. et al. (2010) FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis. Development, 137, 2045-2054.
9. Giulianelli, S., Vaque, J.P., Soldati, R., Wargon, V., Vanzulli, S.I., Martins, R., Zeitlin, E., Molinolo, A.A., Helguero, L.A., Lamb, C.A. et al. (2012) Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters. Cancer Res., 72, 2416-2427.
10. Kong, S.L., Li, G., Loh, S.L., Sung, W.K. and Liu, E.T. (2011) Cellular reprogramming by the conjoint action of ERalpha, FOXA1, and GATA3 to a ligand-inducible growth state. Mol. Syst. Biol., 7, 526.
11. Stender, J.D., Stossi, F., Funk, C.C., Charn, T.H., Barnett, D.H. and Katzenellenbogen, B.S. (2011) The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells. Mol. Endocrinol., 25, 1699-1709.
12. Ross-Innes, C.S., Stark, R., Holmes, K.A., Schmidt, D., Spyrou, C., Russell, R., Massie, C.E., Vowler, S.L., Eldridge, M. and Carroll, J.S. (2010) Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev., 24, 171-182.
13. Hua, S., Kittler, R. and White, K.P. (2009) Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell, 137, 1259-1271.
14. Pradhan, M., Bembinster, L.A., Baumgarten, S.C. and Frasor, J. (2010) Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements. J. Biol. Chem., 285, 31100-31106.
15. Voss, T.C., Schiltz, R.L., Sung, M.H., Yen, P.M., Stamatoyannopoulos, J.A., Biddie, S.C., Johnson, T.A., Miranda, T.B., John, S. and Hager, G.L. (2011) Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell, 146, 544-554.
16. Committee, N.R. (1999) A unified nomenclature system for the nuclear receptor superfamily. Cell, 97, 161-163.
17. Riggio, M., Polo, M.L., Blaustein, M., Colman-Lerner, A., Luthy, I., Lanari, C. and Novaro, V. (2012) PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer. Carcinogenesis, 33, 509-518.
18. Verma, M.K., Miki, Y. and Sasano, H. (2011) Sex steroid receptors in human lung diseases. J. Steroid Biochem. Mol. Biol., 127, 216-222.
19. Amazit, L., Pasini, L., Szafran, A.T., Berno, V., Wu, R.C., Mielke, M., Jones, E.D., Mancini, M.G., Hinojos, C.A., O'Malley, B.W. et al. (2007) Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation. Mol. Cell. Biol., 27, 6913-6932. (Pubitemid 47483640)
20. Ashcroft, F.J., Newberg, J.Y., Jones, E.D., Mikic, I. and Mancini, M.A. (2011) High content imaging-based assay to classify estrogen receptor-alpha ligands based on defined mechanistic outcomes. Gene, 477, 42-52.
21. Berno, V., Amazit, L., Hinojos, C., Zhong, J., Mancini, M.G., Sharp, Z.D. and Mancini, M.A. (2008) Activation of estrogen receptor-alpha by E2 or EGF induces temporally distinct patterns of large-scale chromatin modification and mRNA transcription. PloS One, 3, e2286.
22. Sharp, Z.D., Mancini, M.G., Hinojos, C.A., Dai, F., Berno, V., Szafran, A.T., Smith, K.P., Lele, T.P., Ingber, D.E. and Mancini, M.A. (2006) Estrogen-receptor-alpha exchange and chromatin dynamics are ligand-and domain-dependent. J. Cell Sci., 119, 4101-4116. (Pubitemid 44650882)
23. Cao, Z.D., Barron, E.A. and Sharp, Z.D. (1988) Prolactin upstream factor I mediates cell-specific transcription. Mol. Cell. Biol., 8, 5432-5438.
24. Masood, S. (1992) Immunocytochemical localization of estrogen and progesterone receptors in imprint preparations of breast carcinomas. Cancer, 70, 2109-2114.
25. Brugnatelli, S., Gattoni, E., Grasso, D., Rossetti, F., Perrone, T. and Danova, M. (2011) Single-dose palonosetron and dexamethasone in preventing nausea and vomiting induced by moderately emetogenic chemotherapy in breast and colorectal cancer patients. Tumori, 97, 362-366.
26. Moutsatsou, P. and Papavassiliou, A.G. (2008) The glucocorticoid receptor signalling in breast cancer. J. Cell. Mol. Med., 12, 145-163.
27. Vaidya, J.S., Baldassarre, G., Thorat, M.A. and Massarut, S. (2010) Role of glucocorticoids in breast cancer. Curr. Pharm. Des., 16, 3593-3600.
28. de Hoon, M.J., Imoto, S., Nolan, J. and Miyano, S. (2004) Open source clustering software. Bioinformatics, 20, 1453-1454. (Pubitemid 38931415)
29. Saldanha, A.J. (2004) Java Treeview-extensible visualization of microarray data. Bioinformatics, 20, 3246-3248. (Pubitemid 39619217)
30. Garcia-Becerra, R., Berno, V., Ordaz-Rosado, D., Sharp, Z.D., Cooney, A.J., Mancini, M.A. and Larrea, F. (2010) Ligand-induced large-scale chromatin dynamics as a biosensor for the detection of estrogen receptor subtype selective ligands. Gene, 458, 37-44.
31. Zwart, W., de Leeuw, R., Rondaij, M., Neefjes, J., Mancini, M.A. and Michalides, R. (2010) The hinge region of the human estrogen receptor determines functional synergy between AF-1 and AF-2 in the quantitative response to estradiol and tamoxifen. J. Cell Sci., 123, 1253-1261.
32. McGowan, E.M., Russell, A.J., Boonyaratanakornkit, V., Saunders, D.N., Lehrbach, G.M., Sergio, C.M., Musgrove, E.A., Edwards, D.P. and Sutherland, R.L. (2007) Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor. Cancer Res., 67, 8942-8951. (Pubitemid 47437472)
33. Cvoro, A., Yuan, C., Paruthiyil, S., Miller, O.H., Yamamoto, K.R. and Leitman, D.C. (2011) Cross talk between glucocorticoid and estrogen receptors occurs at a subset of proinflammatory genes. J. Immunol., 186, 4354-4360.
34. Gong, H., Jarzynka, M.J., Cole, T.J., Lee, J.H., Wada, T., Zhang, B., Gao, J., Song, W.C., DeFranco, D.B., Cheng, S.Y. et al. (2008) Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase. Cancer Res., 68, 7386-7393.
35. Watanabe, M., Noda, M. and Nakajin, S. (2007) Aromatase expression in a human osteoblastic cell line increases in response to prostaglandin E(2) in a dexamethasone-dependent fashion. Steroids, 72, 686-692. (Pubitemid 47126563)
36. Lonard, D.M., Nawaz, Z., Smith, C.L. and O'Malley, B.W. (2000) The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol. Cell, 5, 939-948.
37. Madak-Erdogan, Z., Lupien, M., Stossi, F., Brown, M. and Katzenellenbogen, B.S. (2011) Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs. Mol. Cell. Biol., 31, 226-236.
38. Bookout, A.L., Jeong, Y., Downes, M., Yu, R.T., Evans, R.M. and Mangelsdorf, D.J. (2006) Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell, 126, 789-799. (Pubitemid 44233630)
39. Buxant, F., Engohan-Aloghe, C. and Noel, J.C. (2010) Estrogen receptor, progesterone receptor, and glucocorticoid receptor expression in normal breast tissue, breast in situ carcinoma, and invasive breast cancer. Appl. Immunohistochem. Mol. Morphol., 18, 254-257.
40. Pan, D., Kocherginsky, M. and Conzen, S.D. (2011) Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res., 71, 6360-6370.
41. Guo, C.M., Zhu, X.O., Ni, X.T., Yang, Z., Myatt, L. and Sun, K. (2009) Expression of progesterone receptor A form and its role in the interaction of progesterone with cortisol on cyclooxygenase-2 expression in amnionic fibroblasts. J. Clin. Endocrinol. Metab., 94, 5085-5092.
42. Leo, J.C., Guo, C., Woon, C.T., Aw, S.E. and Lin, V.C. (2004) Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells. Endocrinology, 145, 1314-1321. (Pubitemid 38281015)
43. Butler, J.S., Queally, J.M., Devitt, B.M., Murray, D.W., Doran, P.P. and O'Byrne, J.M. (2010) Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation. BMC Musculoskelet. Disord., 11, 210.
44. Hittelman, A.B., Burakov, D., Iniguez-Lluhi, J.A., Freedman, L.P. and Garabedian, M.J. (1999) Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J., 18, 5380-5388. (Pubitemid 29465587)
45. Lee, J. and Safe, S. (2007) Coactivation of estrogen receptor alpha (ER alpha)/Sp1 by vitamin D receptor interacting protein 150 (DRIP150). Arch. Biochem. Biophys., 461, 200-210. (Pubitemid 46677881)
46. Tien, J.C., Zhou, S. and Xu, J. (2009) The role of SRC-1 in murine prostate cancinogenesis is nonessential due to a possible compensation of SRC-3/AIB1 overexpression. Int. J. Biol. Sci., 5, 256-264.
47. Xu, J. and Li, Q. (2003) Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol., 17, 1681-1692. (Pubitemid 37072287)
48. Grenier, J., Trousson, A., Chauchereau, A., Amazit, L., Lamirand, A., Leclerc, P., Guiochon-Mantel, A., Schumacher, M. and Massaad, C. (2004) Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells. Mol. Endocrinol., 18, 2866-2879. (Pubitemid 39577912)
49. Hartig, S.M., He, B., Long, W., Buehrer, B.M. and Mancini, M.A. (2011) Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis. J. Cell Biol., 192, 55-67.
50. Wu, H.Y., Hamamori, Y., Xu, J., Chang, S.C., Saluna, T., Chang, M.F., O'Malley, B.W. and Kedes, L. (2005) Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD. J. Biol. Chem., 280, 3129-3137. (Pubitemid 40223773)